Cargando…
The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key?
Autores principales: | Sciorati, Clara, De Lorenzo, Rebecca, Lorè, Nicola I., Tresoldi, Cristina, Cirillo, Daniela M., Ciceri, Fabio, Corti, Angelo, Manfredi, Angelo A., Rovere-Querini, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734069/ https://www.ncbi.nlm.nih.gov/pubmed/36513209 http://dx.doi.org/10.1016/j.phrs.2022.106601 |
Ejemplares similares
-
Chromogranin A plasma levels predict mortality in COVID-19
por: De Lorenzo, Rebecca, et al.
Publicado: (2022) -
Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2022) -
Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis
por: Ramirez, Giuseppe A., et al.
Publicado: (2015) -
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19
por: Di Filippo, Luigi, et al.
Publicado: (2021) -
Chromogranin-A production and fragmentation in patients with Takayasu arteritis
por: Tombetti, Enrico, et al.
Publicado: (2016)